GERD (acid reflux) — all decisions

The Board granted service connection for Raynaud's disease, chronic tonsillitis, and GERD based on the Veteran's credible reported history of continued symptoms since active duty service.

The appeal for a rating in excess of 10 percent for GERD and for a compensable rating for pharyngitis was dismissed due to the untimely filing of the Notice of Disagreement.

The Board granted an effective date of August 10, 2022, for the award of service connection for GERD and IBS with GERD based on the PACT Act.

The Board granted an initial 30 percent rating for gastroesophageal reflux disease (GERD) effective January 1, 2023.

The Board granted service connection for erectile dysfunction and GERD, but denied service connection for high blood pressure / hypertension. The Board also granted a 10 percent rating for sinus headaches.

The Board denied service connection for a mental health condition and remanded the evaluation of irritable bowel syndrome (IBS) to include gastroesophageal reflux disease (GERD).

The Board denied an initial rating in excess of 30 percent for chronic headaches and denied staged initial ratings for GERD, rated 10 percent prior to August 10, 2022, and rated as 30 percent, with irritable bowel syndrome, from August 10, 2022.

The Board granted service connection for asthma under the PACT Act and denied a higher initial rating for allergic rhinitis. The other issues of entitlement to service connection for chronic sinusitis, GERD, and migraine headaches were remanded.

The appeal for service connection for GERD is dismissed as the March 2025 rating decision granted the benefit in full. The issues of service connection for hypertension and an eye condition are remanded for further development.

The Board remands the claim for service connection of GERD to obtain an addendum opinion from a clinician.

The Board granted a 30 percent rating for the Veteran's service-connected GERD, as the evidence showed considerable impairment of health due to recurrent epigastric distress, reflux, sleep disturbance, nausea, vomiting, and substernal pain.

The Veteran's GERD condition was granted a 30 percent evaluation, effective October 7, 2021.

The Board denied the veteran's claims for a compensable rating for allergic rhinitis and an increased rating for GERD, and remanded the claim for service connection for gallstones/cholelithiasis with gallbladder removal.

The Veteran's appeal for service connection and higher rating was dismissed due to a concurrent election of review options.

The Board denied the veteran's claims for increased ratings and service connection for various conditions, including lumbosacral strain, tinnitus, right knee disability, chronic fatigue syndrome, gastroesophageal reflux disease, bilateral hearing loss, sciatica and lumbar radiculopathy, sleep apnea, and benign paroxysmal positional vertigo.

The Board remands the claims for service connection for a bilateral knee disability, cervical spine disability, obstructive sleep apnea (OSA), and gastroesophageal reflux disease (GERD) as there has not been substantial compliance with previous remand directives.

The Board granted service connection for sleep apnea, GERD, and a heart disability as secondary to the Veteran's posttraumatic stress disorder (PTSD). The claim of entitlement to a TDIU is moot.

The Board remands the claims for a compensable evaluation of gastroesophageal reflux disease (GERD), helicobacter pylori infection, irritable bowel syndrome (IBS), and hemorrhoids to obtain further medical evidence.

The Board granted service connection for asthma and GERD with hiatal hernia, effective from December 5, 2017. The claims for chronic fatigue, herpes simplex, enteritis, and left knee patellofemoral pain syndrome were dismissed.

The Board remands the claims for service connection for GERD and gastritis to correct pre-decisional duty to assist errors.